A non-interventional, multicenter, prospective phase IV study of trabectedin in patients with advanced soft tissue sarcoma
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 24 Oct 2017
At a glance
- Drugs Trabectedin (Primary)
- Indications Soft tissue sarcoma
- Focus Therapeutic Use
- Acronyms Y-IMAGE
- 24 Oct 2017 Results presented in a PharmaMar media release.
- 12 Sep 2017 Results assessing overall versus per country routine real-life use of trabectedin in patients with advanced soft tissue sarcoma across europe, were presented at the 42nd European Society for Medical Oncology Congress.
- 20 Jan 2016 New trial record